Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Cash from Financing Activities (2023 - 2025)

Historic Cash from Financing Activities for Fractyl Health (GUTS) over the last 3 years, with Q3 2025 value amounting to $78.1 million.

  • Fractyl Health's Cash from Financing Activities rose 4810246.91% to $78.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.8 million, marking a year-over-year decrease of 2067.23%. This contributed to the annual value of $101.2 million for FY2024, which is 26893.98% up from last year.
  • Fractyl Health's Cash from Financing Activities amounted to $78.1 million in Q3 2025, which was up 4810246.91% from $1.5 million recorded in Q2 2025.
  • In the past 5 years, Fractyl Health's Cash from Financing Activities registered a high of $101.0 million during Q1 2024, and its lowest value of -$556000.0 during Q4 2023.
  • Moreover, its 3-year median value for Cash from Financing Activities was $162000.0 (2024), whereas its average is $18.9 million.
  • Within the past 5 years, the most significant YoY rise in Fractyl Health's Cash from Financing Activities was 505020000.0% (2024), while the steepest drop was 11785.71% (2024).
  • Fractyl Health's Cash from Financing Activities (Quarter) stood at -$556000.0 in 2023, then surged by 112.05% to $67000.0 in 2024, then surged by 116449.25% to $78.1 million in 2025.
  • Its Cash from Financing Activities stands at $78.1 million for Q3 2025, versus $1.5 million for Q2 2025 and $171000.0 for Q1 2025.